Rodrigo Nel Cordoba Rojas, Esp

Keyphrases

1. Schizophrenia 100%
2. Psychiatrists 90%
3. Latin America (LATAM) 81%
4. Clinical Outcomes 70%
5. Latin American 69%
6. Treatment-resistant Depression 66%
7. Risperidone Long-acting Injection 66%
8. Colombians 66%
9. Colombia 62%
10. Treatment Adherence 50%
11. Bipolar Disorder 50%
12. Patients with Schizophrenia 46%
13. COVID-19 Pandemic 44%
14. Schizophrenic Patients 44%
15. Schizophrenia Treatment 44%
16. Colombian Patients 44%
17. Private Practitioners 29%
18. Mental Health Services 29%
19. Hospitalization 28%
20. First Year 27%
21. Group of People 25%
22. Healthy Controls 24%
23. Global Assessment of Functioning 23%
24. Social Performance 23%
25. Individual Performance 23%
26. Prospective Observational Study 22%
27. Treatment Impact 22%
28. Suicide Trends 22%
29. Psychiatric Assessment 22%
30. First-episode Psychosis 22%
31. Severe Mental Illness 22%
32. Toxoplasma Gondii Infection 22%
33. 2-year Follow-up 22%
34. Year of Diagnosis 22%
35. Esketamine Nasal Spray 22%
36. Psychopharmacotherapy 22%
37. Quetiapine 22%
38. Randomized Placebo-controlled Trial 22%
39. Mood Episode 22%
40. Bipolar I Disorder 22%
41. Remission 22%
42. Consensus Recommendations 22%
43. Program Impact 22%
44. Prognostic Factors 22%
45. Satisfaction Degree 22%
46. Bogota Colombia 22%
47. Schizophrenia Spectrum Disorders 22%
48. Early Course 22%
49. Neurovascular Unit 22%
50. Tear Gas 22%